FindTrial
Sign In

A clinical study on the establishment of key techniques for detection of Tg in patients with TgAb positive differentiated thyroid cancer by liquid chromatography-tandem mass spectrometry (LC-MS/MS)

A clinical study on the establishment of key techniques for detection of Tg in patients with TgAb positive differentiated thyroid cancer by liquid chromatography-tandem mass spectrometry (LC-MS/MS)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055183
Enrollment
Unknown
Registered
2022-01-02
Start date
2022-01-03
Completion date
Unknown
Last updated
2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

differentiated thyroid cancer

Interventions

Gold Standard:Approved Tg assay kits (RIA and chemiluminescence method)
Index test:Thyroglobulin&#32
Detection&#32
Kit

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Samples preserved after routine clinical examination; 2. Sample type: serum; 3. The collection and processing of samples meet the requirements of standard laboratory operations and product instructions; 4. The information of the sample is complete, including age, gender, unique traceable serial number and clinical diagnosis, etc.

Exclusion criteria

Exclusion criteria: 1. The sample does not meet the testing requirements (for example, the sample size is too small); 2. Samples with unclear collection time; 3. Samples with obvious contamination or deterioration; 4. Duplicate samples from the same patient.

Design outcomes

Primary

MeasureTime frame
thyroglobulin;Positive coincidence rate;Negtive coincidence rate;Overall compliance rate;Kappa value;—

Countries

China

Contacts

Public ContactMa Chao

Shanghai Tenth People's Hospital

ponymachao@163.com+86 18721288964

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026